Mylan Drug Company to Release Generic Brand of EpiPen After Public Protest

INTRO:
The drug company Mylan NV has announced it will issue a generic form
of the anti-allergy injectable, EpiPen, after a price spike to $600
caused a public outrage in the US.

EpiPen is a patented method of adrenaline administered during
anaphylactic shock that can be life-saving during an acute allergic
reaction.

Our US Correspondent Laura Cantekin has more.

IN: "The makers of..."
OUT: SOC
DUR: 37

938LIVE: http://www.fsnradionews.com/feeds/0829epipen-lc-938live.mp3
AIR: http://www.fsnradionews.com/feeds/0829epipen-lc-air.mp3
ARN: http://www.fsnradionews.com/feeds/0829epipen-lc-arn.mp3
FM4: http://www.fsnradionews.com/feeds/0829epipen-lc-fm4.mp3
GENERIC: http://www.fsnradionews.com/feeds/0829epipen-lc-generic.mp3
ICRT: http://www.fsnradionews.com/feeds/0829epipen-lc-icrt.mp3
NIGERIA: http://www.fsnradionews.com/feeds/0829epipen-lc-von.mp3
RNZ: http://www.fsnradionews.com/feeds/0829epipen-lc-rnz.mp3
SABC: http://www.fsnradionews.com/feeds/0829epipen-lc-sabc.mp3
SRN: http://www.fsnradionews.com/feeds/0829epipen-lc-srn.mp3
VATICAN: http://www.fsnradionews.com/feeds/0829epipen-lc-vat.mp3
ZIZ: http://www.fsnradionews.com/feeds/0829epipen-lc-ziz.mp3